Clinical uses and control of rifampicin and clindamycin.
作者信息
Phillips I
出版信息
J Clin Pathol. 1971 Jul;24(5):410-8. doi: 10.1136/jcp.24.5.410.
Abstract
摘要
相似文献
1
Clinical uses and control of rifampicin and clindamycin.利福平与克林霉素的临床应用及控制
J Clin Pathol. 1971 Jul;24(5):410-8. doi: 10.1136/jcp.24.5.410.
2
In-vitro comparison of erythromycin, lincomycin, and clindamycin.红霉素、林可霉素和克林霉素的体外比较
Br Med J. 1970 Apr 11;2(5701):89-90. doi: 10.1136/bmj.2.5701.89.
3
Comparative studies of antibacterial activity in vitro and absorption and excretion of lincomycin and clinimycin.
Am J Med Sci. 1968 Nov;256(5):279-92. doi: 10.1097/00000441-196811000-00002.
4
Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents.常见细菌病原体对抗菌药物敏感性模式的变化。
Ann Intern Med. 1972 Jun;76(6):1009-36. doi: 10.7326/0003-4819-76-6-1009.
5
[Value of rifampicin in treatment of the patients with bronchopulmonary lesions. A clinical-bacteriological study].[利福平在支气管肺部病变患者治疗中的价值。一项临床细菌学研究]
Arzneimittelforschung. 1969 Aug;19(8):1283-5.
6
[Laboratory findings on a combination of trimethoprim and sulfamethoxazole].[甲氧苄啶与磺胺甲恶唑联合用药的实验室检查结果]
Dtsch Med Wochenschr. 1971 May 7;96(19):823-4 passim. doi: 10.1055/s-0028-1108340.
7
Bacteriological assessment of clindamycin, a new lincomycin derivative.新型林可霉素衍生物克林霉素的细菌学评估
J Med Microbiol. 1971 Nov;4(4):529-34. doi: 10.1099/00222615-4-4-529.
8
Susceptibility of Diplococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis to 23 antibiotics.肺炎双球菌、流感嗜血杆菌和脑膜炎奈瑟菌对23种抗生素的敏感性
Antimicrob Agents Chemother (Bethesda). 1970;10:53-6.
9
NAFCILLIN. ANTIBACTERIAL ACTION IN VITRO AND ABSORPTION AND EXCRETION IN NORMAL YOUNG MEN.
Am J Med Sci. 1963 Jul;246:10-26. doi: 10.1097/00000441-196307000-00002.
10
Rifampicin: a new rifamycin. I. Bacteriological studies.利福平：一种新型利福霉素。I. 细菌学研究。
Arzneimittelforschung. 1967 May;17(5):523-9.
引用本文的文献
1
Graphitic Carbon Nitride Confers Bacterial Tolerance to Antibiotics in Wastewater Relating to ATP Depletion.石墨相氮化碳赋予废水中细菌对抗生素的耐受性与ATP消耗有关。
Molecules. 2024 Dec 6;29(23):5780. doi: 10.3390/molecules29235780.
2
The Combination of 3-Hydrazinoquinoxaline-2-Thiol with Thymoquinone Demonstrates Synergistic Activity Against Different Strains.3-肼基喹喔啉-2-硫醇与百里醌的组合对不同菌株显示出协同活性。
Infect Drug Resist. 2024 Jun 6;17:2289-2298. doi: 10.2147/IDR.S464287. eCollection 2024.
3
Antibiotics and Bacterial Resistance-A Short Story of an Endless Arms Race.抗生素与细菌耐药性——一场无休止军备竞赛的简史。
Int J Mol Sci. 2023 Mar 17;24(6):5777. doi: 10.3390/ijms24065777.
4
Rifamycin antibiotics and the mechanisms of their failure.利福霉素类抗生素及其耐药机制。
J Antibiot (Tokyo). 2021 Nov;74(11):786-798. doi: 10.1038/s41429-021-00462-x. Epub 2021 Aug 16.
5
Epidemiological Characteristics and Drug Resistance Analysis of Cerebrospinal Fluid Microbial Infections in Wenzhou Area.温州地区脑脊液微生物感染的流行病学特征及耐药性分析
Infect Drug Resist. 2021 Jun 3;14:2091-2103. doi: 10.2147/IDR.S312175. eCollection 2021.
6
Evaluation of human primary intestinal monolayers for drug metabolizing capabilities.评估人源原代肠单层细胞的药物代谢能力。
J Biol Eng. 2019 Nov 4;13:82. doi: 10.1186/s13036-019-0212-1. eCollection 2019.
7
Rifampin combination therapy for nonmycobacterial infections.利福平联合疗法治疗非分枝杆菌感染。
Clin Microbiol Rev. 2010 Jan;23(1):14-34. doi: 10.1128/CMR.00034-09.
8
New antibacterial drugs.新型抗菌药物。
Br Med J. 1971 Oct 16;4(5780):129-30.
9
Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens.实验性链球菌性心内膜炎的化疗。I. 常用推荐预防方案的比较。
J Clin Invest. 1973 Mar;52(3):592-8. doi: 10.1172/JCI107220.
10
Failure of rifampin to inhibit adenovirus replication.利福平无法抑制腺病毒复制。
Antimicrob Agents Chemother. 1972 Oct;2(4):326-8. doi: 10.1128/AAC.2.4.326.
本文引用的文献
1
The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin.葡萄球菌及其他伤口细菌对红霉素、竹桃霉素和螺旋霉素的敏感性。
J Clin Pathol. 1959 Mar;12(2):163-9. doi: 10.1136/jcp.12.2.163.
2
Chemical modification of lincomycin.林可霉素的化学修饰
Antimicrob Agents Chemother (Bethesda). 1966;6:727-36.
3
[Studies on the use of 7-chlor-7-desoxylincomycin in pediatrics].
Arzneimittelforschung. 1969 Jun;19(6):1003-6.
4
The antibiotic susceptibility of Mycoplasma hominis.人型支原体的抗生素敏感性
J Clin Pathol. 1969 Jul;22(4):483-5. doi: 10.1136/jcp.22.4.483.
5
Hemodialysis properties of clindamycin (7-chloro-7-deoxylincomycin).克林霉素（7-氯-7-去氧林可霉素）的血液透析特性
Appl Microbiol. 1969 Mar;17(3):446-8. doi: 10.1128/am.17.3.446-448.1969.
6
Bacteriologic studies of rifampin, a new semisynthetic antibiotic.新型半合成抗生素利福平的细菌学研究
J Infect Dis. 1969 Feb;119(2):132-7. doi: 10.1093/infdis/119.2.132.
7
Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin.
Antimicrob Agents Chemother (Bethesda). 1968;8:392-7.
8
Absorption, excretion and half-life of clinimycin in normal adult males.克林霉素在正常成年男性中的吸收、排泄及半衰期
Am J Med Sci. 1968 Jul;256(1):25-37. doi: 10.1097/00000441-196807000-00004.
9
Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man.利福平：一种新型利福霉素。3. 人体中的吸收、分布及消除
Arzneimittelforschung. 1967 May;17(5):534-7.
10
Comparison of in vitro antibacterial activities of 7-chloro-7-deoxylincomycin, lincomycin, and erythromycin.7-氯-7-脱氧林可霉素、林可霉素和红霉素的体外抗菌活性比较
Antimicrob Agents Chemother (Bethesda). 1967;7:397-400.
Zotero 插件